Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
0.3837
-0.0147 (-3.69%)
Feb 9, 2026, 12:45 PM EST - Market open
Autonomix Medical Employees
As of March 31, 2025, Autonomix Medical had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$1,517,455
Market Cap
2.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 11 | 3 | 37.50% | 8 | 3 |
| Mar 31, 2024 | 8 | 4 | 100.00% | 5 | 3 |
| Mar 31, 2023 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 292 |
| WORK Medical Technology Group LTD | 238 |
| STRATA Skin Sciences | 106 |
| Nuwellis | 38 |
| ENvue Medical | 31 |
| Catheter Precision | 22 |
| Aethlon Medical | 9 |
| Tivic Health Systems | 7 |
AMIX News
- 4 weeks ago - Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - GlobeNewsWire
- 6 weeks ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - GlobeNewsWire
- 7 weeks ago - Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - GlobeNewsWire
- 2 months ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference - GlobeNewsWire
- 4 months ago - Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit - GlobeNewsWire
- 4 months ago - Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - GlobeNewsWire
- 4 months ago - Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - GlobeNewsWire